Don't Recommend Baxdela to Treat Most Skin Infections

Baxdela (baks-DEH-lah, delafloxacin) is a new quinolone antibiotic.

So far it's only approved to treat skin infections.

It seems to have better coverage than other quinolones for gram-positive bacteria...including methicillin-resistant Staph aureus (MRSA).

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 300+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote